Evofem Biosciences, Inc. Quarterly Interest Expense in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Evofem Biosciences, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q1 2024.
  • Evofem Biosciences, Inc. Interest Expense for the quarter ending March 31, 2024 was $564K, a 0.18% decline year-over-year.
  • Evofem Biosciences, Inc. annual Interest Expense for 2023 was $2.27M, a 4.32% increase from 2022.
  • Evofem Biosciences, Inc. annual Interest Expense for 2022 was $2.18M, a 18.3% decline from 2021.
  • Evofem Biosciences, Inc. annual Interest Expense for 2021 was $2.67M, a 29.3% increase from 2020.
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $564K -$1K -0.18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $565K +$42K +8.03% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $523K -$629K -54.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-06-16
Q1 2021 $1.15M +$1.15M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.